Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of Zolpidem tartrate
10 mg tablets (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by TEVA
Pharmaceuticals USA) with that of AMBIEN® tablets(G.D. Searle & Co.) in healthy, adult,
non-smoking subjects under non-fasting conditions.